Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,384 total articles
Change Agents Corp. (Nasdaq: CHGA) announced its membership in the Institute for Defense and Government Advancement (IDGA) and participation in the upcoming Counter UAS Summit to advance its strategy in the AI-powered autonomous air defense and counter-unmanned aerial systems market. The company recently established Autonomous Air Defense LLC, a su…
Vivos Therapeutics has expanded its partnership with Greenway Health to deploy the AI-driven Novare platform across its clinical operations, beginning at Sleep Centers of Nevada. This initiative aims to increase patient capacity, improve revenue cycle efficiencies, reduce administrative labor costs, and support Vivos' growth strategy in the sleep m…
Wearable Devices Ltd. announced that the U.S. Patent and Trademark Office granted a continuation patent on their gesture and voice-controlled interface device that uniquely authenticates users through combined gesture and biopotential sensors analyzing neural signals. This patent strengthens their intellectual property portfolio and supports new us…
Myseum.AI, a privacy-focused AI and social media technology company, has introduced a new user acquisition platform collaborating with 34 non-profit organizations, including affiliates of Special Olympics and YMCA, to promote its private photo and video sharing app, Picture Party. This partnership leverages the organizations' collective reach of ov…
Companhia Siderúrgica Nacional (CSN), via its subsidiary CSN Inova Ventures, announced successful completion of a private exchange offer and consent solicitation involving its 6.750% Senior Notes due 2028. The offer allowed eligible note holders to exchange their 2028 Notes for new 11.000% Senior Notes due 2030 plus cash. Approximately 77.49% of ou…
Nocera, Inc. announced it has fully resolved all Nasdaq listing compliance matters by exceeding the minimum stockholders' equity requirement with $5.4 million, more than double the $2.5 million minimum. This regulatory milestone concludes previous concerns allowing the company to redirect efforts toward strategic acquisitions and growth initiatives…
Idaho Copper Corporation announced the appointment of four independent directors, bringing extensive expertise in mining development, public company audit, commodities trading, and Idaho permitting. Alongside these appointments, the company formed Audit, Compensation, and Nominating and Corporate Governance committees, establishing an independent m…
Reborn Coffee Inc. announced a Strategic Memorandum of Understanding with The Mighty Oak Inc. to enter the U.S. produce supply business. Leveraging The Mighty Oak's vendor relationships with major Asian-American grocery chains, Reborn Coffee aims to diversify beyond specialty coffee by sourcing, importing, and supplying agricultural products to the…
SurgePays, a US-based wireless and fintech company, reported significant growth in its smartphone rent-to-own program with LowWeeklyPayments, hitting $176,000 in retail sales for July, a 23% increase from June. The program, targeting subprime consumers, shows strong potential to become a distinct revenue channel and is under consideration for expan…
Intelligent Bio Solutions has completed its multi-site Method Comparison Study for its Intelligent Fingerprinting Drug Screening System, a significant milestone for its FDA 510(k) submission targeting U.S. market clearance for opiate detection. The study, conducted across three U.S. clinical sites with a diverse participant base, demonstrated the s…
NeoVolta Inc., a U.S.-based energy storage technology company, announced its participation schedule for upcoming investor conferences taking place virtually and in-person during August and September 2026. Management will engage in one-on-one meetings to discuss company progress and developments, including updates on its new manufacturing facility.
Conexeu Sciences Inc., a Nasdaq-listed preclinical-stage biotech company that develops extracellular matrix-based tissue restoration technologies, announced that its Chief Medical Officer, Dr. Brian Pilcher, will present at the 2026 Controversies & Conversations in Laser & Cosmetic Surgery Symposium. The presentation covers the company's novel ECM …
Cingulate Inc. announced the publication of peer-reviewed pharmacokinetic data for CTx-1301, its lead ADHD treatment candidate. The study shows that CTx-1301 delivers a unique trimodal release of dexmethylphenidate, offering rapid onset and sustained medication coverage throughout the active day with fewer adverse events than existing treatments. T…
BIO-key International announced a warrant inducement transaction with an institutional investor involving the exercise of warrants to purchase 618,334 shares at a reduced price, generating approximately $2.5 million in gross proceeds. In return, the company will issue new unregistered warrants subject to stockholder approval, enhancing its capital …
RenovoRx, Inc. has completed full patient enrollment in its Phase III TIGeR-PaC trial, evaluating its novel intra-arterial gemcitabine therapy delivered via the FDA-cleared RenovoCath device to treat locally advanced pancreatic cancer (LAPC). The trial aims to demonstrate improved overall survival and reduced toxicity compared to standard systemic …
Achieve Life Sciences reported its second quarter 2026 financial results, highlighted a private placement of up to $354 million, and detailed progress on transitioning cytisinicline drug manufacturing to the U.S. The company received a Complete Response Letter from the FDA citing manufacturing and labeling issues but no clinical safety or efficacy …
SolarMax Technology, Inc. announced a 1-for-12 reverse stock split effective August 13, 2026, aimed at increasing its stock price to meet Nasdaq's minimum $1 bid price requirement. The company continues to face compliance challenges related to minimum market value of listed securities and faces possible delisting if not resolved by year-end. The re…
First Advantage Corporation disclosed the pricing of a secondary offering involving 12.5 million shares sold by investment funds affiliated with Silver Lake Group. The company itself is not issuing new shares nor receiving proceeds from this offering. The transaction is expected to close by August 12, 2026, with J.P. Morgan Securities acting as und…
Big Digital Energy, Inc. announced a letter of intent with Tensor IQ LLC to develop a 17 megawatt AI and HPC infrastructure campus in Hood County, Texas. The project will feature high-density digital infrastructure, including deployment of 7,748 NVIDIA GPUs and advanced cooling systems, aiming to begin operations by Q2 2027. This agreement is expec…
GMEX Robotics Corporation updates shareholders on progress in executing its integrated 'Terminal + Brain' ecosystem strategy. Key developments include the planned acquisition of a significant stake in social-intelligence AI firm MediaMeta.Ai, a Letter of Intent for a physical AI connectivity company to enhance robot fleet communication latency, and…
Cloudastructure, Inc., a Nasdaq-listed provider of AI-powered video surveillance and cloud-based security analytics, announced that its management will present and hold one-on-one investor meetings at Sidoti & Company's Micro-Cap Virtual Investor Conference on August 19-20, 2026.
Locafy Limited, a SaaS company specializing in location-based SEO and AEO solutions, appointed Liz Willits as Chief Marketing Officer on a fractional basis to spearhead marketing strategy and accelerate recurring revenue growth. Willits will lead the go-to-market launch of Proteus™, Locafy's AI-powered website generation technology designed to deli…
PDS Biotechnology Corporation announced a strategic prioritization of its tumor-targeted immunocytokine PDS0301, focusing on its advancement in metastatic colorectal cancer and other solid tumors, while seeking partnerships for the continued development of PDS0101. The company highlights encouraging Phase 2 clinical data for PDS0301, especially in …
Mereo BioPharma reported a net loss reduction in Q2 2026 compared to Q2 2025, extended cash runway into late 2027, and entered a key option and license agreement with Sentynl Therapeutics for alvelestat, targeting alpha-1 antitrypsin deficiency-associated lung disease. The company is engaging with regulators on setrusumab for osteogenesis imperfect…
Catheter Precision, Inc.'s subsidiary Flyte announced a strategic partnership with The Nucleus Network to support their inaugural flagship founder and investor event. This collaboration highlights Flyte's commitment to embedding itself within the entrepreneurial and venture capital ecosystem through networking and relationship-building. Flyte aims …
